Extensive financial links between the leaders of US oncology professional associations and the pharmaceutical industry have raised concerns over independence and integrity. More than A$84 million (US$55.6m) in industry payments flowed to leaders of the American Society of Clinical Oncology (ASCO) over a five year period according to figures published in BMJ. Oncologists were ahead ...
Professional medical societies criticised for financial entanglements with industry
By Michael Woodhead
2 Jun 2020